TLDR: Blue Spa, a veteran medaesthetic practice in Sherman Oaks, California, has launched a 90-day pilot program utilizing Trinity Aesthetics’ Generative and Agentic AI technology. This initiative aims to revolutionize patient engagement and sales by offering hyperpersonalized skincare regimens, streamlined product purchasing, and efficient procedure scheduling. This marks the first known application of such advanced AI in the medspa sector, with the goal of serving nearly 30,000 clients with tailored skincare plans.
SHERMAN OAKS, Calif. & MIAMI – September 30, 2025 – A significant advancement in the medaesthetic industry was announced today as Blue Spa, a long-standing independent provider in Sherman Oaks, California, commenced a pilot program for new Generative and Agentic Artificial Intelligence (AI) technology developed by Trinity Aesthetics. This pioneering initiative is set to transform patient engagement and sales through the delivery of hyperpersonalized skincare regimens, coupled with effortless product purchasing and procedure scheduling.
Blue Spa, a renowned Los Angeles-based medspa, is leading the charge in integrating #GenAI to offer bespoke #skincare solutions to its extensive client base, which currently exceeds 20,000. The company anticipates expanding this reach to nearly 30,000 clients through the new technology. This 90-day program is believed to be the first known application of Agentic and Generative Artificial Intelligence directly within the medspa sector.
Ronda Nofal, founder of Blue Spa, expressed her enthusiasm for the collaboration, stating, “Trinity’s purpose-built software specifically addresses key industry pain points no other software attempts, while empowering our providers to deliver hyperpersonalized skincare plans to nearly 30,000 clients.” Nofal highlighted Blue Spa’s 26-year history of innovation, including pioneering injectables and device technology, noting that software capable of maintaining patient-provider connections throughout the skincare journey is a ‘game-changer.’
Joseph Panetta, CEO of Trinity Aesthetics, commented on the pilot launch, emphasizing the unique value proposition of their technology. “There is an abundance of software targeting cosmetic dermatology and medspa practices, but none foster continued meaningful patient engagement and enhance sales opportunities. We’re designed by operators for operators,” Panetta explained. He added that working with Blue Spa provides an ‘excellent proving ground’ for their technology, serving some of the most discerning aesthetic clients globally. Panetta also revealed the scale of the undertaking, stating, “This is one of the largest AgenticAI pilots of a live iOS platform ever conducted. We will be sharing results as they unfold over the course of our 90-day program.”
Also Read:
- Generative AI Poised to Revolutionize Dermatology Workflows, Says Miiskin CEO Jon Friis
- Perfect Corp. Forum Highlights Generative AI’s Transformative Impact on Beauty and Fashion Personalization
Trinity Aesthetics, founded in 2016, initially focused its Generative AI technology on providing datasets to beauty product manufacturers. Following successful collaborations with the R&D teams of Procter & Gamble and Estee Lauder Companies for upstream product development, Trinity’s management identified an opportunity to create a platform that seamlessly connects medspa providers, patients, and products. This platform integrates via API into existing software, enhancing the provider-patient relationship and facilitating frictionless, perpetual hyperpersonalized skincare routines. The move aligns with industry insights, as McKinsey has identified hyperpersonalization as the future of skincare.
